482598-29-8

Upstream product

• 72648-80-7 ethyl 2-[2-(tert-butoxycarbonylamino)ethyl-[3-[[4-(4,5-difluoro-2-methylsulfanyl-phenyl)phenoxy]methyl]benzoyl]amino]acetate 
• 482598-28-7 [8-(3-benzyloxycarbonylamino-propoxy)-2-oxo-2,9-dihydro-10-oxa-1,3,9-triaza-anthracen-3-yl]-acetic acid 
• 482598-26-5 {4-[2-(3-benzyloxycarbonylamino-propoxy)-6-hydroxy-phenylamino]-5-bromo-2-oxo-2H-pyrimidin-1-yl}-acetic acid ethyl ester 
• 482598-27-6 [8-(3-benzyloxycarbonylamino-propoxy)-2-oxo-2,9-dihydro-10-oxa-1,3,9-triaza-anthracen-3-yl]-acetic acid ethyl ester 
• 476454-38-3 [5-bromo-4-(2,6-dihydroxy-phenylamino)-2-oxo-2H-pyrimidin-1-yl]-acetic acid ethyl ester 
• 381710-01-6 5-bromo-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidineacetic acid ethyl ester 

Relevant academic research and scientific papers

High-Affinity Peptide Nucleic Acid Oligomers Containing Tricyclic Cytosine Analogues

(Matrix Presented) Peptide nucleic acid (PNA) monomers containing the tricyclic cytosine analogues phenoxazine, 9-(2-aminoethoxy)phenoxazine (G-clamp), and 9-(3-aminopropoxy)phenoxazine (propyl-G-clamp) have been synthesized. The modified nucleobases were